Viriome Overview

  • Founded
  • 2007
Founded
  • Status
  • Private
  • Latest Deal Type
  • Undetermined

Viriome General Information

Description

Operator of an antiviral company. The company develops drugs to treat infectious diseases such as HCV, West Nile virus, dengue, measles, RSV and HIV/AIDS.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • 929 South High Street
  • West Chester, PA 19382
  • United States
+1 (610) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Viriome Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Undetermined 000 Completed
2. Early Stage VC 000 000 Completed
1. Early Stage VC (Series A) 30-Sep-2007 $8M $8M 000.00 Completed Product Development
To view Viriome’s complete valuation and funding history, request access »

Viriome Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A3 000,000 00.000000 00 000.00 000.00 00 000.00 00.000
Series A2 00,000 00.000000 00 000.00 000.00 00 000.00 00.000
Series A1 15,955 $0.000100 8% $62.68 $62.68 1x $62.68 2.66%
To view Viriome’s complete cap table history, request access »